Show simple item record

dc.contributor.authorSøreide, Kjetil
dc.contributor.authorStättner, Stefan
dc.contributor.authorHallet, Julie
dc.date.accessioned2024-01-30T14:49:22Z
dc.date.available2024-01-30T14:49:22Z
dc.date.created2023-12-19T08:58:58Z
dc.date.issued2023
dc.identifier.issn1068-9265
dc.identifier.urihttps://hdl.handle.net/11250/3114611
dc.description.abstractSmall bowel neuroendocrine tumors (SB-NETs) are increasingly identified and have become the most frequent entity among small bowel tumors. An increasing incidence, a high prevalence, and a prolonged survival with optimal modern multidisciplinary management makes SB-NETs a unique set of tumors to consider for surgical oncologists. The major goals of surgical treatment in the setting of SB-NET include control of tumor volume, control of endocrine secretion, and prevention of locoregional complications. Key considerations include assessment of multifocality and resection of mesenteric nodal masses with the use of mesenteric-sparing approaches and acceptance of R1 margins if necessary to clear disease while avoiding short bowel syndrome. A description through eight steps for consideration is presented to allow for systematic surgical planning and execution of resection. Moreover, some controversies and evolving considerations to the surgical principles and technical procedures remain. The role of primary tumor resection in the presence of (unresectable) liver metastasis is still unclear. Reports of feasibility of minimally invasive surgery are emerging, with undetermined selection criteria for appropriateness or long-term outcomes. Resection of SB-NETs should be considered in all patients fit for surgery and should follow principles to achieve surgical oncological control that is appropriate for the stage and tumor burden, considering the age and comorbidity of the individual patient.en_US
dc.language.isoengen_US
dc.publisherSpringeren_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleSurgery as a Principle and Technical Consideration for Primary Tumor Resection of Small Bowel Neuroendocrine Tumorsen_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2023 The Author(s)en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.1245/s10434-023-14610-0
dc.identifier.cristin2215266
dc.source.journalAnnals of Surgical Oncologyen_US
dc.source.pagenumber1125-1137en_US
dc.identifier.citationAnnals of Surgical Oncology. 2023, 31, 1125-1137.en_US
dc.source.volume31en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal